Every Test News Today

Our guide bridges this evolving landscape with timeless techniques that stand the test of time. Let's delve into the strategies that will help you conquer any exam.

England have had 17 months to reboot and plot out their revenge after the 4-0 humiliation in Australia in the previous series, and heres how you can watch Ashes 2023 for free.

Pakistan opener Abdullah Shafique has thrown away his wicket simply minutes earlier than the lunch break to present Australia its first breakthrough.

(0) RARITAN, N.J., April 13, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the worlds largest pure-play in vitro diagnostics companies, today announced it received CE Marking for its VITROS SARS-CoV-2 Antigen Test, initially launched in October 2020. The CE Mark allows for more convenient sample collection and expanded viral transport media. "Regions across the world are in various stages of reopening and recovering, yet there remains a great need for reliable tests th...

Ortho Clinical Diagnostics Announces Pricing of Initial Public Offering News provided by Share this article Share this article RARITAN, N.J., Jan. 27, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics Holdings plc ("Ortho"), the worlds largest pure-play in vitro diagnostics company dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions, today announced the pricing of its initial public offering of 76 million ordinary shares at $17.00 per share. T...

Ortho Clinical Diagnostics Announces Launch of Initial Public Offering RARITAN, N.J., Jan. 19, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics Holdings plc ("Ortho"), the worlds largest pure-play in vitro diagnostics company dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions, today announced the launch of its initial public offering of its ordinary shares. Ortho is offering 70 million ordinary shares, with the initial public offering price e...

Share this article Share this article - Orthos VITROS® SARS-CoV-2 Antigen Test is the first high-volume COVID-19 antigen test to receive Food and Drug Administration (FDA) Emergency Use Authorization (EUA). - With utility for mass-scale testing and same-day results for labs, Orthos latest COVID-19 solution can run up to 130 tests per hour. - The test is run on Orthos high-volume VITROS® Systems, which are installed in over 5,600 laboratories around the world with 1,500 installed in the U.S. ...

Orthos VITROS SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First High-Volume Test to Receive FDA Emergency Use Authorization i, clinically reliable results on Orthos high-volume VITROS Systems, which are installed in over 5,600 laboratories around the world. More than 1,500 VITROS analyzers are operational across the U.S. - including more than 500 located in rural regions, where coronavirus testing needs are especially urgent. These analyzers normally run a broad m...